Ophthalmology, Cornea and External Diseases Specialist · Waco, TX
NPI
1407291420
Since 2013
Specialty
Ophthalmology, Cornea and External Diseases Specialist
Code 207WX0120X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
201 Londonderry Dr
Waco, TX, 76712
Phone (254) 772-4499
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
2,600 services
Medicare patients, 2024
459
Average age 73
Drug cost, 2024
$1.7M
3,552 prescriptions
Company payments, 2025
$14K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Forrest B Swann was code J1096 (dexamethasone, lacrimal ophthalmic insert, 0.1 mg), 332 times for 53 patients. In total Forrest B Swann billed 2,600 services in 64 codes, and Medicare paid $374K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1096 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | Office | 332 | 53 | $108.48 | $36K |
| 92136 Ultrasound - Nonspecific | Office | 296 | 166 | $27.74 | $8,210 |
| 66984 Cataract Surgery | Facility | 218 | 130 | $388.81 | $85K |
| 66821 Cataract Surgery | Office | 218 | 129 | $246.79 | $54K |
| 99213 Office E&M - Established | Office | 192 | 92 | $68.08 | $13K |
| 92025 Test - Miscellaneous | Office | 109 | 102 | $25.08 | $2,733 |
| 92012 Ophthalmological E&M | Office | 97 | 66 | $55.05 | $5,340 |
| 76514 Ultrasound - Nonspecific | Office | 88 | 72 | $7.49 | $659 |
| 68841 Eye | Office | 85 | 53 | $28.54 | $2,426 |
| 99212 Office E&M - Established | Office | 80 | 58 | $38.65 | $3,092 |
| 92014 Ophthalmological E&M | Office | 66 | 65 | $73.23 | $4,833 |
| 99214 Office E&M - Established | Office | 60 | 45 | $91.98 | $5,519 |
| 99204 Office E&M - New | Office | 58 | 58 | $97.04 | $5,628 |
| 65778 Eye | Office | 58 | 19 | $819.24 | $48K |
| 92134 Computerized Ophthalmic Imaging | Office | 56 | 48 | $26.03 | $1,458 |
By year: 2022 $481K for 3,123 services; 2023 $447K for 2,825 services; 2024 $374K for 2,600 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 30 | 18 | $22.03 | $661 |
Medicare prescription drug claims, 2024
In 2024, the drug Forrest B Swann prescribed most often to Medicare patients was Ofloxacin, with 712 prescriptions and refills. In total Forrest B Swann wrote 3,552 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofloxacin Generic | 712 | 725 | 495 | $8,226 |
| Latanoprost Generic | 589 | 956 | 131 | $5,064 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 436 | 843 | 124 | $6,669 |
| Prednisolone Acetate Generic | 378 | 431 | 236 | $13K |
| Prolensa Bromfenac Sodium | 219 | 278 | 144 | $77K |
| Brimonidine Tartrate Generic | 180 | 278 | 53 | $3,327 |
| Miebo Perfluorohexyloctane/Pf | 150 | 160 | 80 | $116K |
| Timolol Maleate Generic | 99 | 181 | 24 | $950 |
| Lotemax Sm Loteprednol Etabonate | 80 | 94 | 44 | $21K |
| Bromfenac Sodium Generic | 79 | 88 | 52 | $14K |
| Acyclovir Generic | 72 | 95 | 24 | $752 |
| Dorzolamide Hcl Generic | 55 | 96 | 19 | $1,233 |
| Vyzulta Latanoprostene Bunod | 53 | 66 | 16 | $20K |
| Alprazolam Generic | 47 | 47 | 34 | $29.25 |
| Oxervate Cenegermin-Bkbj | 34 | 34 | Under 11 | $1.3M |
Brand drugs: 1,315 claims; generic drugs: 2,237 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Forrest B Swann $14K ($14K in general payments such as food, travel and fees) from 17 companies. The largest payer was Bausch & Lomb Americas Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 21 | $11K |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 4 | $1,837 |
| Lumibird Medical Inc. | 1 | $340 |
| Amgen Inc. AMGN | 8 | $275 |
| Biotissue Holdings Inc. | 2 | $208 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $203 |
| Sight Sciences, Inc. SGHT | 5 | $167 |
| LENSAR, Inc. LNSR | 2 | $98.87 |
| RxSight Inc RXST | 1 | $97.62 |
| Abbvie Inc. ABBV | 3 | $89.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.